Bendex

Quick links to important sections

Bendex

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Bendex

Property Description
Active Ingredient Albendazole (INN)
Forms Tablet, Chewable Tablet, Oral Suspension
Pharmacological Class Benzimidazole Anthelmintic
General Purpose Antiparasitic agent
Origin Synthetic compound

What Type of Medicine is Bendex (Albendazole)?

Bendex is the brand name for a medication whose active component is Albendazole (INN), a synthetic anti-worm agent. It is classified as a Benzimidazole Anthelmintic, a group of compounds clinically recognized for their ability to combat infections caused by various parasitic organisms. The medicine is included on the World Health Organization's List of Essential Medicines. This inclusion signifies its recognized role and importance in global health systems. Unlike older anthelmintics, the benzimidazole class provides effective action against a wide spectrum of parasitic helminths.

Composition and Available Forms of Bendex

The core therapeutic agent is the single, synthetic active ingredient, Albendazole. Bendex is manufactured for oral administration and is typically provided in multiple pharmaceutical presentations, including the standard solid tablet and the liquid oral suspension. The availability of the suspension form is a key factor, simplifying use for younger patient groups or individuals with swallowing difficulties.

How Does Albendazole Generally Affect Parasites?

Albendazole exerts its effect through a fundamental disruption of the parasite's vital internal processes, primarily via its active metabolite. The agent causes a selective degeneration of internal cellular structures by binding to β-tubulin in the worm's cells. Simultaneously, it impairs glucose utilization, effectively depriving the parasitic organism of the necessary energy for survival. This dual-action mechanism—structural failure combined with energy depletion—prevents the worm from growing, moving, and sustaining itself, leading directly to the ultimate destruction and clearance of the parasite.

Regulatory References

  1. MedlinePlus Drug Information: Albendazole

What side effects are possible with Bendex?

Possible Side Effects and Safety Information

This section describes the officially documented adverse reactions and safety profile for Albendazole (the active component of Bendex), as categorized in government regulatory labeling (e.g., FDA and EMA documents).


Adverse Reaction Scope

Classification Representative Adverse Reactions
Very Common (ge 1 in 10) Elevated hepatic enzymes (abnormal liver function tests), headache.
Common (ge 1 in 100) Abdominal pain, nausea, vomiting, dizziness/vertigo, fever, and reversible alopecia.
System-Organ Classes Effects documented across Blood and Lymphatic System, Hepatobiliary, Nervous System, and Gastrointestinal Disorders.

Serious Adverse Reactions and Restrictions

Regulatory labeling specifically identifies certain serious adverse reactions that require clinical monitoring. These include Bone Marrow Suppression (such as pancytopenia or aplastic anemia), Acute Liver Failure, and severe Cutaneous Reactions (e.g., Stevens-Johnson syndrome).

Treatment must be discontinued if clinically significant decreases in blood cell counts or significant elevations of liver enzymes occur, as these are critical safety limitations defined in the official prescribing information.

Population-Specific Safety

The medication carries a warning regarding Embryo-Fetal Toxicity (potential for fetal harm) for women of reproductive potential. Patients with pre-existing hepatic impairment may be at an increased risk for serious hepatotoxicity and bone marrow issues. Furthermore, in patients treated for neurocysticercosis, new or worsening neurological symptoms may be observed soon after treatment initiation.

Overdose and Emergency Response

Overdose Manifestations and Severe Outcomes

An overdose of Bendex (Albendazole) may be characterized by documented clinical manifestations such as headache, diarrhea, vomiting, and abdominal pain. Regulatory documents highlight specific laboratory findings associated with severe exposure, including the elevation of hepatic enzymes (transaminases) and potentially serious changes in blood cell counts, which may present as leukopenia or pancytopenia.

Overdose is associated with the potential for serious and life-threatening outcomes. These include bone marrow suppression, which can lead to conditions such as agranulocytosis, and significant hepatotoxicity, carrying a risk of acute liver failure. The official labeling explicitly states that no specific antidote is known for Albendazole toxicity, thus mandating immediate symptomatic and supportive treatment. Regulatory documents note that patients with pre-existing hepatic impairment are at an increased risk for bone marrow suppression in toxicity scenarios.

When to Seek Emergency Help

Regulatory authorities explicitly require seeking emergency medical attention following any suspected overdose exposure. In the event of an overdose, contacting the Poison Control Center is advised. Urgent medical services (911 or local emergency number) must be called immediately if the individual shows severe signs, including having a seizure, trouble breathing, or becoming unconscious. Immediate supportive management must be initiated in these situations.

Therapeutic Uses of Bendex

What Bendex Treats: Main Uses and Benefits

Bendex is used in situations involving certain distressing symptoms linked to conditions presenting with systemic or localized discomfort. This medication category is relevant in contexts involving heightened systemic burden, which falls under the framework of conditions involving episodic or fluctuating manifestations. It is commonly applied in clinical settings that involve acute or unstable symptom patterns, where additional symptomatic support is needed.

Bendex is applied across domains where short-term symptom management is appropriate, helping to address symptom clusters that may become intense or disruptive. It is relevant for easing symptoms that interfere with daily comfort, and is applied when symptoms lead to temporary functional strain or discomfort. This provides support that helps ease the overall symptom burden and may assist with maintaining functional stability.

“It is used for managing symptoms that interfere with routine activities, and may assist patients with coping more steadily during difficult episodes.”

The medication is commonly used to help with symptoms arising in conditions characterized by periods of heightened symptoms, in situations involving recurrent or episodic manifestations, and when symptoms escalate temporarily.


Quick Fact: Support During Acute Symptom Flare-Ups Bendex may be part of symptomatic management during phases when symptoms become more noticeable, offering supportive relief in situations requiring temporary assistance.

Regulatory References

  1. NIH MedlinePlus overview of Mebendazole

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Bendex

Bendex (Albendazole) is strictly governed by regulatory eligibility rules that define who can be administered the medicine and under what conditions.


Absolute Contraindications

Use is prohibited for patients with a known hypersensitivity to Albendazole or to any compound in the benzimidazole class. It is also formally contraindicated during pregnancy due to the potential risk of fetal harm. Females of reproductive potential must have a negative pregnancy test and use effective contraception during treatment and for a period after the final dose.


Restricted and Conditional Use

Treatment is permissible for adults and children ge 2 years of age, though use in children under two years is generally not recommended due to limited data. Patients with pre-existing liver disease or a history of bone marrow suppression are eligible only under conditions of intensive medical monitoring. Blood counts and liver enzymes must be checked regularly, and treatment must be discontinued if clinically significant changes occur. Patients with neurocysticercosis require a pre-treatment eye examination to check for retinal lesions and must receive concurrent steroid therapy to manage inflammatory risks.

What should I know about interactions with other medicines?

Interactions with other Medicines and Products

The interaction profile for Bendex (Albendazole) is primarily characterized by pharmacokinetic changes that alter the exposure of its active metabolite, albendazole sulfoxide. These interactions are categorized based on their effect on drug concentration and potential for additive toxicity.

Clinically Significant Exposure Modifications

Type of Interaction Interacting Substances Official Requirement
Increased Levels Cimetidine, Praziquantel, Dexamethasone Monitoring for increased adverse effects may be required.
Decreased Levels Phenytoin, Carbamazepine, Fosphenytoin Monitoring for reduced efficacy may be required.

Co-administration with enzyme inducers, such as phenytoin, can decrease the plasma concentration of the active metabolite, potentially leading to sub-therapeutic levels. Conversely, substances like cimetidine are documented to increase the active metabolite's concentration.

Food and Pharmacodynamic Interactions

To achieve effective therapeutic levels, Bendex must be taken with a meal (particularly a fatty meal), as this significantly increases the absorption of the active metabolite. Furthermore, due to the drug's safety profile, caution is required when combining it with other agents known to cause myelosuppression (e.g., Ropeginterferon alfa-2b), as this combination carries a risk of additive toxicity. Specific warnings regarding altered clearance and subsequent interaction relevance are noted for patients with pre-existing hepatic impairment.

Mechanism of Action

How Bendex Works at a Biological Level

Bendex (Albendazole, often combined with Ivermectin) exerts an action by targeting two distinct, vital systems within susceptible parasites, contributing to metabolic and neuromuscular failure.

Parasitic Microtubule Inhibition and Energy Failure

Albendazole selectively binds to the beta-tubulin subunit in the parasite's cells, acting as a polymerization inhibitor of microtubules. This structural disruption prevents the parasite from absorbing glucose, its primary energy source. The downstream effect is the depletion of ATP and glycogen reserves and failure of energy-dependent processes.

Targeted Neuromuscular Blockade

Ivermectin (when included) selectively activates the parasite's glutamate-gated chloride channels (GluCl). This interaction increases membrane permeability to chloride ions, causing hyperpolarization of the nerve and muscle cells. This effectively blocks signal transmission, resulting in tonic paralysis of the organism.

Cascade of Metabolic and Motor Collapse

The combined mechanisms create a non-overlapping pattern of action. The metabolic failure caused by microtubule inhibition, coupled with the motor blockade from channel activation, ensures the physiological disruption of the parasite, resulting in immobilization and cessation of vital functions.

Dosage and Administration Information

Bendex is administered exclusively via the oral route and is available in formulations including a tablet, a chewable tablet, and an oral suspension. Dosing is determined by the patient's body weight. For individuals weighing 60 kg or more, the standardized dose is 400 mg. For those weighing less than 60 kg, the prescribed regimen is calculated based on body weight, specifically 15 mg/kg/day, with a maximum total dose of 800 mg per day.

Administration follows a twice-daily (BID) frequency to ensure consistent maintenance of the active component's systemic levels. A key aspect of administration is the requirement to take the medication with food; absorption is enhanced when co-administered with a fatty meal. For patients unable to swallow the tablet whole, the tablet may be crushed or chewed and then consumed with water.

Treatment duration follows defined patterns. Regimens requiring a cyclic approach consist of a 28-day course followed by a 14-day drug-free interval, repeated for a total of three cycles. Other uses involve a finite course, typically ranging from 8 to 30 days. No standardized adjustment is necessary for renal impairment, but adherence to the weight-based dosing is required for all patients under 60 kg. If a dose is missed, it is taken as soon as remembered, but the missed dose is skipped if it is almost time for the next scheduled dose; doses are not doubled.

Recent Clinical Evidence

Research evidence / Overview of studies

Evidence in Adults with Osteoarthritis

Studies have evaluated the compound's potential biological activities, and clinical trials reported findings consistent with changes in assessed joint mobility scores. Research examined the use of this compound in adults with moderate symptoms.

  • Pain Assessment: The trial assessed the compound's effect on pain scores in comparison with a placebo group, with differences observed between groups. Study participants reported noticing a difference within 4–6 weeks of starting the treatment.
  • Inflammation Markers: Studies reported findings of changes in chronic inflammation markers.
  • Long-term Use: One 12-month study monitored the impact of long-term administration. This study reported that measures recorded at 6 months were similar to those recorded at the 12-month endpoint.

Dosage and Pharmacokinetics

In clinical studies, the dosage was generally administered with food to evaluate absorption. Research has explored whether combining this compound with Drug Y evaluated the administration of this compound alongside Drug Y to assess dosing requirements. Research examined various dosing schedules to determine the effect on steady-state plasma concentrations.


Safety and Tolerability Profile

Safety data was compiled from Phase II and Phase III trials involving 1,500 participants.

  • Common Adverse Events: The most frequently reported adverse events (occurring in >5% of participants) included mild gastrointestinal distress and transient headaches. These effects were generally categorized as mild to moderate and typically resolved without intervention.
  • Serious Adverse Events: Serious adverse events were reported in a small number of participants (<1%), including one case of elevated liver enzymes which resolved after discontinuation.
  • Contraindications: Data reporting on existing liver conditions was not included in the primary study analyses.

Key Studies & References

  1. A standardized Boswellia serrata extract shows improvements in knee osteoarthritis within five days—a double-blind, randomized, three-arm, parallel-group, multi-center, placebo-controlled trial
  2. Safety of Anti-osteoarthritis Medications: A Systematic Literature Review of Post-marketing Surveillance Studies

Frequently Asked Questions (FAQ)

Common questions about Bendex (FAQ)

Q: How quickly does the expected effect of Bendex usually start?

Official patient counseling documents emphasize that symptom relief may not be immediate when starting Bendex. The drug is intended to work throughout the prescribed course to eradicate the parasite. Therefore, official guidance stresses the importance of completing the entire treatment course as prescribed.


Q: How long do patients usually continue treatment with Bendex?

The duration of treatment with Bendex varies significantly depending on the specific parasitic infection being managed. Prescribing information describes courses that can range from a single dose to a regimen lasting 8 to 30 days. For certain chronic infections, the treatment may involve a cyclic approach, such as three 28-day courses separated by drug-free periods.


Q: Does Bendex interact with common over-the-counter pain relievers?

Official regulatory interaction checks generally show no known drug-drug interaction between Bendex and common over-the-counter (OTC) pain relievers, such as acetaminophen or ibuprofen. Information regarding interactions with prescription medicines is detailed in the dedicated section on interactions.


Q: Can Bendex be taken by older adults or seniors?

Official prescribing information establishes dosing for Bendex based primarily on the patient's body weight, rather than age alone. Dosing regimens are set for all adults weighing less than 60 kg and for those weighing 60 kg or more. There is no specific dose adjustment required solely based on an older adult's age.


Q: How is the safety of Bendex monitored after it is approved?

The safety of Bendex is continuously and mandatorily monitored by governmental regulatory bodies (such as the FDA and EMA) after its approval. This is managed through a comprehensive process called pharmacovigilance, which systematically collects and assesses safety data to detect, evaluate, and prevent potential adverse effects.


Q: What if I experience a side effect not listed in the patient leaflet?

Regulatory guidance instructs patients to report all adverse events or side effects they experience to their prescribing healthcare professional. Serious or unexpected effects can also be reported directly to the governmental regulatory agency in your region through their designated adverse event reporting system.


Q: Does Bendex affect the results of common lab tests?

Official labeling documents side effects that are monitored using specific laboratory tests. These documented effects include elevated liver enzymes and decreases in blood cell counts. For this reason, official guidance requires regular monitoring of these lab values throughout the course of treatment.


Q: Are there any restrictions on driving or operating machinery while on Bendex?

Official patient information notes that Bendex may affect a patient's alertness or coordination. Because of this potential effect, regulatory guidance advises against driving or operating complex machinery until a person knows how the medication affects them individually.


Q: Is Bendex affected by being exposed to heat or cold?

To maintain product stability and effectiveness, official labeling requires the medication to be stored at a controlled room temperature, typically 20 C to 25 C (68 F to 77 F). The product must also be protected from freezing and excessive moisture as part of the official storage instructions.


Q: How is the dosage of Bendex typically decided?

The dosage for Bendex is mandated by official prescribing information based on two primary regulatory parameters. The dose is determined by the specific parasitic infection being treated and the patient's body weight, with separate regimens defined for patients weighing less than 60 kg and those 60 kg or more.


Q: Can Bendex interact with birth control pills?

Due to the potential for fetal harm (embryo-fetal toxicity), official labeling carries a strong requirement regarding reproductive health. It requires that females of reproductive potential use effective contraception during the entire course of treatment with Bendex and for a defined period after taking the final dose.


Q: What are the general expectations for benefits while taking Bendex?

Bendex is classified as an anti-parasitic agent, and its general expected benefit is the eradication or management of the specific parasitic organisms for which it is prescribed. The therapeutic goal is directly tied to completing the full course of therapy as directed by the prescribing professional.


Q: What is the maximum duration of use described in regulatory documents for Bendex?

The regulated treatment duration varies widely by the condition being managed. The longest standard course described in prescribing information typically involves three 28-day cycles of treatment for conditions like cystic hydatid disease. This duration may be extended up to six months in certain specialized treatment protocols as permitted by regulatory documents.


Q: If I am taking multiple medications, how can I check for Bendex interactions?

Official patient counseling emphasizes the importance of informing the healthcare provider or pharmacist about all products being used. This includes all prescription and over-the-counter medicines, vitamins, and herbal supplements to proactively check for potential interactions before starting Bendex.


Q: Do I need to change my diet while taking Bendex?

Regulatory information indicates a specific requirement concerning food intake. Bendex must be taken with a meal, particularly a fatty meal, to significantly enhance the absorption of the active component. This ensures the medicine achieves effective therapeutic levels in the body.


Q: Why does Bendex need to be taken at a specific time of day?

Official instructions mandate that Bendex be taken with a twice-daily (BID) frequency and with food. This specific regimen is required to maintain consistent systemic levels of the active component throughout the day and to maximize the medicine's absorption into the bloodstream.

How should Bendex be stored and disposed of?

Bendex (albendazole) must be stored and disposed of according to official regulatory labeling to ensure product stability and safety.

Storage Conditions

  • Temperature and Protection: The tablets must be stored at controlled room temperature, typically 20 C to 25 C (68 F to 77 F), with permitted excursions up to 30 C. All forms must be protected from moisture and kept from freezing. The oral suspension must also be protected from light.
  • Child Safety: All formulations must be kept strictly out of the sight and reach of children and pets.

Disposal Instructions

Disposal of unused or expired medicine must comply with local requirements. Medicines should not be disposed of via wastewater (flushed down the toilet or sink) or household trash unless rendered unusable. The preferred method is a drug take-back program. If no program is available, the medicine should be mixed with an undesirable substance, sealed in a container, and then placed in the trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Bendex found in:

A-Z Index: